Handa Oncology receives FDA final approval for OMCAZIO cabozantinib
FDA granted final approval for OMCAZIO (cabozantinib) capsules, including administration without regard to food and removal of strict fasting requirements for cabozantinib patients.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.